ULTRAGENYX PHARMACEUTICAL INC. (RARE) Gross profit 2017–2018
ULTRAGENYX PHARMACEUTICAL INC. (RARE) annual gross profit history from SEC filings — each fiscal year as reported.
$50.3MFY2018 · since FY2017: $2.6M → $50.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | $50.3M | +1828.3% |
| FY2017 | $2.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice